Estados financieros detallados de IRIDEX Corporation (IRIX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
IRIDEX Corporation registró ingresos de $52.7M en el último ejercicio fiscal, con un CAGR de 5 años del 7.7%.
Márgenes de los últimos 12 meses: margen bruto 36.2%, margen operativo -5.4%, margen neto -6.9%.
Al precio actual de $0.61, IRIX presenta beneficios negativos (P/E no significativo) y un ROE del -78.94%. La capitalización bursátil es de $11M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|
| Ingresos | $46.2M | $41.6M | $42.6M | $43.4M | $36.3M | $53.9M | $57.0M | $51.9M | $48.7M | $52.7M |
| Coste de Ventas | $25.3M | $26.1M | $25.1M | $25.5M | $20.8M | $31.1M | $31.6M | $30.1M | $29.2M | $33.4M |
| Beneficio Bruto | $20.8M | $15.5M | $17.5M | $17.9M | $15.6M | $22.8M | $25.4M | $21.8M | $19.5M | $19.3M |
| I+D | $5.4M | $5.7M | $4.0M | $3.7M | $3.3M | $6.9M | $7.2M | $6.8M | $5.4M | $3.7M |
| Generales y Administrativos | $17.9M | $22.8M | $26.3M | $23.2M | $18.9M | $23.5M | $25.7M | $25.0M | $22.4M | $18.1M |
| Gastos Operativos | $23.3M | $28.5M | $30.3M | $26.9M | $22.1M | $30.4M | $32.9M | $31.8M | $27.8M | $21.9M |
| Beneficio Operativo | -$2.6M | -$12.9M | -$12.9M | -$9.0M | -$6.6M | -$7.5M | -$7.5M | -$10.0M | -$8.3M | -$2.6M |
| EBITDA | -$1.8M | -$12.2M | -$12.1M | -$8.3M | -$6.1M | -$4.4M | -$6.1M | -$7.4M | -$7.4M | -$2.8M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$2.7M | -$13.0M | -$12.8M | -$8.8M | -$6.3M | -$5.2M | -$7.5M | -$9.5M | -$8.8M | -$4.4M |
| Impuestos | $9.1M | -$128000 | $37000 | $48000 | $26000 | $40000 | $65000 | $90000 | $68000 | $57000 |
| Beneficio Neto | -$11.7M | -$12.9M | -$12.8M | -$8.8M | -$6.3M | -$5.2M | -$7.5M | -$9.6M | -$8.9M | -$4.4M |
| BPA | $-1.15 | $-1.11 | $-1.05 | $-0.64 | $-0.46 | $-0.34 | $-0.47 | $-0.59 | $-0.54 | $-0.26 |
| BPA Diluido | $-1.15 | $-1.11 | $-1.05 | $-0.64 | $-0.46 | $-0.34 | $-0.47 | $-0.59 | $-0.54 | $-0.26 |
| Acciones en Circulación (Diluidas) | $10.2M | $11.6M | $12.2M | $13.7M | $13.8M | $15.4M | $15.9M | $16.1M | $16.4M | $17.2M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2026-Q1 | 2026-Q2 | 2026-Q3 |
|---|
| Ingresos | $12.5M | $14.7M | $11.8M | $12.6M |
| Beneficio Bruto | $4.0M | $5.6M | $4.7M | $4.3M |
| Beneficio Operativo | -$1.4M | -$15000 | -$324000 | -$1.0M |
| EBITDA | -$1.2M | $258000 | -$94000 | -$666999 |
| Beneficio Neto | -$1.6M | -$184000 | -$524000 | -$1.3M |
| BPA | $-0.09 | $-0.01 | $-0.03 | $-0.07 |
| BPA Diluido | $-0.09 | $-0.01 | $-0.03 | $-0.07 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|
| Caja y Equivalentes | $23.7M | $21.7M | $21.2M | $12.7M | $11.6M | $23.9M | $13.9M | $7.0M | $2.4M | $6.0M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $10.0M | $7.9M | $9.1M | $9.3M | $7.3M | $9.7M | $9.8M | $9.7M | $8.4M | $9.5M |
| Inventario | $11.6M | $9.4M | $8.8M | $8.2M | $5.7M | $7.6M | $10.6M | $9.9M | $10.8M | $7.9M |
| Activos Corrientes | $45.9M | $39.5M | $39.6M | $30.6M | $25.4M | $42.3M | $35.8M | $27.4M | $23.6M | $25.3M |
| Inmovilizado Material | $1.5M | $1.4M | $1.2M | $3.5M | $1.9M | $3.0M | $2.1M | $3.0M | $1.9M | $826000 |
| Fondo de Comercio | $533000 | $533000 | $533000 | $533000 | $533000 | $965000 | $965000 | $965000 | $965000 | $965000 |
| Activos Intangibles | $132000 | $116000 | $100000 | $84000 | $68000 | $2.2M | $2.0M | $1.6M | $1.3M | $984000 |
| Activos Totales | $48.1M | $41.6M | $41.7M | $34.8M | $28.0M | $48.7M | $42.3M | $34.4M | $29.1M | $29.2M |
| Cuentas por Pagar | $2.0M | $1.7M | $2.5M | $2.6M | $1.1M | $2.8M | $3.9M | $4.5M | $7.0M | $5.4M |
| Deuda a Corto | 0 | 0 | 0 | 0 | $1.2M | 0 | 0 | 0 | $1.7M | 0 |
| Pasivos Corrientes | $8.5M | $10.4M | $11.1M | $9.8M | $8.7M | $12.6M | $12.5M | $13.0M | $16.6M | $13.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $1.2M | 0 | 0 | 0 | $1.0M | $3.7M |
| Pasivos Totales | $9.0M | $11.1M | $11.7M | $12.1M | $10.6M | $25.4M | $25.1M | $24.9M | $27.0M | $24.2M |
| Reservas | -$16.1M | -$29.0M | -$41.8M | -$50.6M | -$56.9M | -$62.2M | -$69.7M | -$79.0M | -$88.0M | -$92.4M |
| Patrimonio Neto | $39.2M | $30.5M | $30.0M | $22.7M | $17.4M | $23.3M | $17.2M | $9.5M | $2.1M | $4.9M |
| Deuda Total | 0 | 0 | 0 | $3.2M | $4.2M | $2.7M | $1.8M | $2.7M | $4.6M | $4.5M |
| Deuda Neta | -$23.7M | -$21.7M | -$21.2M | -$9.4M | -$7.4M | -$21.2M | -$12.2M | -$4.3M | $2.3M | -$1.5M |
| Capital Circulante | $37.4M | $29.1M | $28.5M | $20.8M | $16.7M | $29.6M | $23.3M | $14.5M | $7.0M | $12.0M |
Balance (Trimestral)
| Año | 2025-Q3 | 2026-Q1 | 2026-Q2 | 2026-Q3 |
|---|
| Caja y Equivalentes | $5.6M | $6.0M | $4.6M | $4.7M |
| Activos Totales | $28.4M | $29.2M | $28.3M | $27.3M |
| Pasivos Totales | $23.7M | $24.2M | $23.5M | $23.6M |
| Patrimonio Neto | $4.7M | $4.9M | $4.7M | $3.6M |
| Deuda Total | $4.8M | $4.5M | $4.3M | $4.0M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|
| Beneficio Neto | -$11.7M | -$12.9M | -$12.8M | -$8.8M | -$6.3M | -$5.2M | -$7.5M | -$9.6M | -$8.9M | -$4.4M |
| Amortizaciones | $648000 | $858000 | $809000 | $688000 | $504000 | $1.7M | $1.4M | $2.0M | $1.4M | $1.5M |
| Compensación en Acciones | $1.8M | $1.9M | $1.8M | $1.7M | $1.1M | $1.6M | $1.6M | $1.6M | $1.2M | $775000 |
| Cambio en Capital Circulante | -$222000 | $6.4M | $23000 | -$1.6M | $1.3M | $12.6M | -$5.2M | -$857000 | -$1.4M | -$2.4M |
| Flujo de Caja Operativo | -$144000 | -$3.6M | -$10.0M | -$7.9M | -$3.2M | $8.2M | -$9.5M | -$6.7M | -$7.3M | -$2.1M |
| Inversiones (CapEx) | -$1.1M | -$575000 | -$440000 | -$128000 | -$97000 | -$213000 | -$286000 | -$109000 | -$13000 | -$143000 |
| Adquisiciones | -$406000 | -$382000 | -$387000 | 0 | 0 | -$5.3M | 0 | 0 | 0 | 0 |
| Recompra de Acciones | -$59000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$1.2M | -$4.1M | -$10.5M | -$8.0M | -$3.3M | $8.0M | -$9.8M | -$6.9M | -$7.3M | -$2.3M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2026-Q1 | 2026-Q2 | 2026-Q3 |
|---|
| Flujo de Caja Operativo | -$1.2M | $589000 | -$1.3M | $174000 |
| Inversiones (CapEx) | -$13000 | -$24000 | -$101000 | $101000 |
| Flujo de Caja Libre | -$1.2M | $565000 | -$1.4M | $275000 |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $92000 | $213000 | $211000 | $212000 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|
| Crecimiento Ingresos (anual) | | -9.9% | +2.4% | +2.0% | -16.3% | +48.3% | +5.7% | -9.0% | -6.2% | +8.2% |
| Crecimiento Beneficio Neto (anual) | | -9.9% | +0.4% | +31.2% | +28.2% | +17.4% | -44.4% | -26.8% | +6.9% | +50.2% |
| Crecimiento BPA (anual) | | +3.5% | +5.4% | +39.0% | +28.1% | +26.1% | -38.2% | -25.5% | +8.5% | +51.9% |
| Cambio en Acciones (anual) | | +13.6% | +5.6% | +12.4% | +1.0% | +11.4% | +3.4% | +1.2% | +1.9% | +4.6% |
| Crecimiento FCF (anual) | | -243.3% | -152.8% | +23.2% | +58.5% | +340.1% | -222.5% | +30.1% | -6.5% | +69.1% |
| Margen Bruto | 45.1% | 37.3% | 41.0% | 41.3% | 42.8% | 42.4% | 44.5% | 42.0% | 40.1% | 36.7% |
| Margen Operativo | -5.6% | -31.0% | -30.2% | -20.7% | -18.1% | -14.0% | -13.2% | -19.3% | -17.1% | -4.9% |
| Margen EBITDA | -3.9% | -29.3% | -28.3% | -19.1% | -16.7% | -8.1% | -10.7% | -14.4% | -15.2% | -5.4% |
| Margen Neto | -25.4% | -30.9% | -30.1% | -20.3% | -17.4% | -9.7% | -13.2% | -18.5% | -18.3% | -8.4% |
| Margen FCF | -2.6% | -10.0% | -24.6% | -18.5% | -9.2% | 14.8% | -17.2% | -13.2% | -15.0% | -4.3% |
| Tasa Impositiva Efectiva | -341.0% | 1.0% | -0.3% | -0.5% | -0.4% | -0.8% | -0.9% | -0.9% | -0.8% | -1.3% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|
| FCF por Acción | $-0.12 | $-0.36 | $-0.86 | $-0.59 | $-0.24 | $0.52 | $-0.62 | $-0.42 | $-0.44 | $-0.13 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $10.2M | $11.6M | $12.2M | $13.7M | $13.8M | $15.4M | $15.9M | $16.1M | $16.4M | $17.2M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -78.94% |
| Rentabilidad sobre capital invertido | -19.53% |
| Rentabilidad sobre activos | -13.01% |
| Margen bruto | 36.23% |
| Margen operativo | -5.39% |
| Margen neto | -6.88% |
Salud financiera
| Deuda / Patrimonio | 1.10 |
| Ratio corriente | 1.82 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -1.93 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|
| P/E | -12.23 | -6.86 | -4.48 | -3.48 | -5.46 | -17.97 | -4.28 | -4.76 | -3.11 | -4.50 |
| P/VC | 3.65 | 2.88 | 1.91 | 1.35 | 2.00 | 4.04 | 1.86 | 4.76 | 13.17 | 4.09 |
| P/V | 3.10 | 2.12 | 1.35 | 0.70 | 0.96 | 1.75 | 0.56 | 0.87 | 0.57 | 0.38 |
| Margen Bruto | 45.1% | 37.3% | 41.0% | 41.3% | 42.8% | 42.4% | 44.5% | 42.0% | 40.1% | 36.7% |
| Margen Operativo | -5.6% | -31.0% | -30.2% | -20.7% | -18.1% | -14.0% | -13.2% | -19.3% | -17.1% | -4.9% |
| Margen Neto | -25.4% | -30.9% | -30.1% | -20.3% | -17.4% | -9.7% | -13.2% | -18.5% | -18.3% | -8.4% |